116 related articles for article (PubMed ID: 7638434)
21. The SCID-hu mouse as a model for HIV-1 infection.
Aldrovandi GM; Feuer G; Gao L; Jamieson B; Kristeva M; Chen IS; Zack JA
Nature; 1993 Jun; 363(6431):732-6. PubMed ID: 8515816
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.
Scoggins RM; Taylor JR; Patrie J; van't Wout AB; Schuitemaker H; Camerini D
J Virol; 2000 Apr; 74(7):3205-16. PubMed ID: 10708437
[TBL] [Abstract][Full Text] [Related]
23. Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells.
Markham RB; Schwartz DH; Templeton A; Margolick JB; Farzadegan H; Vlahov D; Yu XF
J Virol; 1996 Oct; 70(10):6947-54. PubMed ID: 8794338
[TBL] [Abstract][Full Text] [Related]
24. Suppression of HIV infection in AZT-treated SCID-hu mice.
McCune JM; Namikawa R; Shih CC; Rabin L; Kaneshima H
Science; 1990 Feb; 247(4942):564-6. PubMed ID: 2300816
[TBL] [Abstract][Full Text] [Related]
25. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
26. In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.
Jamieson BD; Pang S; Aldrovandi GM; Zha J; Zack JA
J Virol; 1995 Oct; 69(10):6259-64. PubMed ID: 7666526
[TBL] [Abstract][Full Text] [Related]
27. The SCID-hu mouse: an in vivo model for HIV-1 infection in humans.
Bonyhadi ML; Kaneshima H
Mol Med Today; 1997 Jun; 3(6):246-53. PubMed ID: 9211415
[TBL] [Abstract][Full Text] [Related]
28. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
[TBL] [Abstract][Full Text] [Related]
29. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288.
Agatsuma T; Abe K; Furukawa H; Koga R; Koizumi M; Hotoda H; Kaneko M
Antiviral Res; 1997 May; 34(3):121-30. PubMed ID: 9191019
[TBL] [Abstract][Full Text] [Related]
30. Simple i.v. inoculation of HIV-1 to Thy/Liv SCID-hu mice induce reproducible HIV infection with narrowing of medulla in human thymic implant.
Okamoto Y; Ogura A; Shibata S; Amagai T; Katsura Y; Asano T; Honda M
J Vet Med Sci; 1997 Apr; 59(4):259-63. PubMed ID: 9152933
[TBL] [Abstract][Full Text] [Related]
31. thy/liv-SCID-hu mice: a system for investigating the in vivo effects of multidrug therapy on plasma viremia and human immunodeficiency virus replication in lymphoid tissues.
Pettoello-Mantovani M; Kollmann TR; Katopodis NF; Raker C; Kim A; Yurasov S; Wiltshire H; Goldstein H
J Infect Dis; 1998 Feb; 177(2):337-46. PubMed ID: 9466519
[TBL] [Abstract][Full Text] [Related]
32. HIV-1-associated pathology in hemato-lymphoid organs and the experimental evaluation in the SCID-hu mouse.
Kaneshima H
Int J Hematol; 1996 Jun; 63(4):253-64. PubMed ID: 8762809
[TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse.
Stanley SK; McCune JM; Kaneshima H; Justement JS; Sullivan M; Boone E; Baseler M; Adelsberger J; Bonyhadi M; Orenstein J
J Exp Med; 1993 Oct; 178(4):1151-63. PubMed ID: 8376927
[TBL] [Abstract][Full Text] [Related]
34. Thy/Liv-SCID-Hu mice implanted with human intestine: an in vivo model for investigation of mucosal transmission of HIV.
Gibbons C; Kollmann TR; Pettoello-Mantovani M; Kim A; Goldstein H
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1453-60. PubMed ID: 9390744
[TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.
Camerini D; Su HP; Gamez-Torre G; Johnson ML; Zack JA; Chen IS
J Virol; 2000 Apr; 74(7):3196-204. PubMed ID: 10708436
[TBL] [Abstract][Full Text] [Related]
36. Human dendritic cells transduced with herpes simplex virus amplicons encoding human immunodeficiency virus type 1 (HIV-1) gp120 elicit adaptive immune responses from human cells engrafted into NOD/SCID mice and confer partial protection against HIV-1 challenge.
Gorantla S; Santos K; Meyer V; Dewhurst S; Bowers WJ; Federoff HJ; Gendelman HE; Poluektova L
J Virol; 2005 Feb; 79(4):2124-32. PubMed ID: 15681415
[TBL] [Abstract][Full Text] [Related]
37. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus infection of xenografted SCID-beige mice.
McBride BW; Easterbrook LM; Farrar GH
J Med Virol; 1995 Oct; 47(2):130-8. PubMed ID: 8830116
[TBL] [Abstract][Full Text] [Related]
39. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
40. Predictive efficacy of SCID-hu mouse models for treatment of human cytomegalovirus infections.
Kern ER; Rybak RJ; Hartline CB; Bidanset DJ
Antivir Chem Chemother; 2001; 12 Suppl 1():149-56. PubMed ID: 11594682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
